Clinics (Sao Paulo). 2021;76:e2483.
Management of Respiratory Failure Caused by COVID-19 after Thoracoscopic Esophagectomy
Flavio Roberto Takeda
, Carlos de Almeida Obregon
, Yasmin Peres Navarro
, Marco Aurélio Santo Filho
, Ulysses Ribeiro Junior
, Rubens Antônio Aissar Sallum
, Ivan Cecconello
DOI: 10.6061/clinics/2021/e2483
BACKGROUND
Since December 2019, with the first descriptions of cases of pneumonia caused by the new coronavirus in Wuhan, China, the virus causing this infection has spread globally (). One of the main characteristics of this new virus is its high transmissibility ().
Since February 2020, when the first coronavirus disease 2019 (COVID-19) case was reported in Brazil, a series of changes have been incorporated for the treatment of cancer patients with COVID-19. In particular, for patients with esophageal cancer, additional precautions have been taken, as surgery for esophageal cancer alone has higher morbidity and mortality rates compared to that for other oncological surgeries (). In this context, severe acute respiratory syndrome (SARS) caused by COVID-19 can pose a serious risk to the patient.
[…]
18
